CAPP2: a randomised chemoprevention trial of aspirin and resistant starch in Lynch Syndrome

被引:0
|
作者
Burn, John [1 ]
Bishop, D. T. [2 ]
Mecklin, J-P [3 ]
Macrae, F. [4 ]
Moeslein, G. [5 ]
Olschwang, S. [6 ]
Bisgaard, M. L. S. [7 ]
Ramesar, R. [8 ]
Jass, J. [8 ]
Lynch, H. T. [9 ]
Barker, G. [1 ]
Elliott, F. [2 ]
Mathers, J. C. M. [10 ]
机构
[1] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England
[2] Univ Leeds, Inst Mol Med, Leeds, W Yorkshire, England
[3] Jyvaskyla Cent Hosp, Dept Surg, Jyvaskyla, Finland
[4] Royal Melbourne Hosp, Melbourne, Vic, Australia
[5] St Josef Hosp, Bochum, Germany
[6] Inst J Paoli I Calmettes, F-13009 Marseille, France
[7] Univ Copenhagen, Copenhagen, Denmark
[8] Univ Cape Town, Div Human Genet, ZA-7925 Cape Town, South Africa
[9] Creighton Univ, Med Ctr, Dept Prevent Med & Publ Hlth, Omaha, NE USA
[10] Univ Newcastle, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:S16 / S16
页数:1
相关论文
共 50 条
  • [1] CAPP2: An international controlled trial of aspirin and resistant starch in carriers of HNPCC
    Burn, J
    Chapman, PD
    Mathers, J
    Bishop, DT
    Lynch, H
    [J]. JOURNAL OF MEDICAL GENETICS, 1997, 34 : 518 - 518
  • [2] Lynch Syndrome: History, Causes, Diagnosis, Treatment and Prevention (CAPP2 Trial)
    Burn, John
    Mathers, John
    Bishop, D. Tim
    [J]. DIGESTIVE DISEASES, 2012, 30 : 39 - 47
  • [3] Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
    Topping, David L.
    Bird, Anthony R.
    Young, Graeme P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14): : 1462 - 1462
  • [4] Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
    Burn, John
    Bishop, D. Timothy
    Mecklin, Jukka-Pekka
    Macrae, Finlay
    Moeslein, Gabriela
    Olschwang, Sylviane
    Bisgaard, Marie-Luise
    Ramesar, Raj
    Eccles, Diana
    Maher, Eamonn R.
    Bertario, Lucio
    Jarvinen, Heikki J.
    Lindblom, Annika
    Evans, D. Gareth
    Lubinski, Jan
    Morrison, Patrick J.
    Ho, Judy W. C.
    Vasen, Hans F. A.
    Side, Lucy
    Thomas, Huw J. W.
    Scott, Rodney J.
    Dunlop, Malcolm
    Barker, Gail
    Elliott, Faye
    Jass, Jeremy R.
    Fodde, Ricardo
    Lynch, Henry T.
    Mathers, John C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (24): : 2567 - 2578
  • [5] Results of the CAPP-2-trial (Aspirin and resistant starch) in HNPCC gene carriers
    Burn, J.
    Bishop, D. T.
    Mecklin, J.
    Macrae, F.
    Moeslein, G.
    Olschwang, S.
    Bisgaard, M.
    Ramesar, R.
    Elliott, F.
    Mathers, J.
    [J]. EJC SUPPLEMENTS, 2008, 6 (03): : 25 - 25
  • [6] Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
    Mathers, John C.
    Movahedi, Mohammad
    Macrae, Finlay
    Mecklin, Jukka-Pekka
    Moeslein, Gabriela
    Olschwang, Sylviane
    Eccles, Diana
    Evans, Gareth
    Maher, Eamonn R.
    Bertario, Lucio
    Bisgaard, Marie-Luise
    Dunlop, Malcolm
    Ho, Judy W. C.
    Hodgson, Shirley
    Lindblom, Annika
    Lubinski, Jan
    Morrison, Patrick J.
    Murday, Victoria
    Ramesar, Raj
    Side, Lucy
    Scott, Rodney J.
    Thomas, Huw J. W.
    Vasen, Hans
    Gerdes, Anne-Marie
    Barker, Gail
    Crawford, Gillian
    Elliott, Faye
    Pylvanainen, Kirsi
    Wijnen, Juul
    Fodde, Riccardo
    Lynch, Henry
    Bishop, D. Timothy
    Burn, John
    [J]. LANCET ONCOLOGY, 2012, 13 (12): : 1242 - 1249
  • [7] The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?
    Patrick M. Lynch
    [J]. Familial Cancer, 2021, 20 : 9 - 11
  • [8] The CAPP II trial of aspirin in Lynch syndrome/HNPCC: is it time for everyone to be treated?
    Lynch, Patrick M.
    [J]. FAMILIAL CANCER, 2021, 20 (01) : 9 - 11
  • [9] CAPP2 RCT: Resistant Starch Planned Long-term Follow-up-Letter
    Nielsen, Maartje
    van Duijnhoven, Franzel J. B.
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (01) : 57 - 57
  • [10] Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
    Burn, John
    Gerdes, Anne-Marie
    Macrae, Finlay
    Mecklin, Jukka-Pekka
    Moeslein, Gabriela
    Olschwang, Sylviane
    Eccles, Diane
    Evans, D. Gareth
    Maher, Eamonn R.
    Bertario, Lucio
    Bisgaard, Marie-Luise
    Dunlop, Malcolm G.
    Ho, Judy W. C.
    Hodgson, Shirley V.
    Lindblom, Annika
    Lubinski, Jan
    Morrison, Patrick J.
    Murday, Victoria
    Ramesar, Raj
    Side, Lucy
    Scott, Rodney J.
    Thomas, Huw J. W.
    Vasen, Hans F.
    Barker, Gail
    Crawford, Gillian
    Elliott, Faye
    Movahedi, Mohammad
    Pylvanainen, Kirsi
    Wijnen, Juul T.
    Fodde, Riccardo
    Lynch, Henry T.
    Mathers, John C.
    Bishop, D. Timothy
    [J]. LANCET, 2011, 378 (9809): : 2081 - 2087